Facing remarks from your inner circle about your GLP-1 treatment, how to respond with confidence and serenity while preserving your emotional well-being.
Why does your inner circle react to GLP-1 treatment?
Taking an anti-obesity medication like tirzepatide (Mounjaro) or semaglutide often elicits reactions from those around you. These reactions are explained by several factors: a lack of understanding of the biological mechanisms of obesity, persistent prejudices about willpower and weight, and intense media coverage of GLP-1 treatments that fuels fantasies and misconceptions.
According to a study published in Obesity Reviews (2023), 78% of patients undergoing anti-obesity treatment report receiving unsolicited comments from their inner circle. These remarks, even if well-intentioned, can generate stress, guilt, and compromise therapeutic adherence. The World Obesity Federation (WOF) emphasizes that social stigma remains one of the main obstacles to obesity treatment.
The most frequent types of remarks
Comments from your inner circle generally fall into several categories. Moralizing remarks (“You just need to go on a diet”) are based on the false idea that obesity is simply a lack of willpower. Alarmist comments (“These injections are dangerous”) reflect a lack of understanding of clinical data. Comparative reflections (“My neighbor lost weight without medication”) minimize the individual complexity of the disease.
Other remarks touch on identity: “You won’t be yourself anymore” or “It’s cheating.” These comments reveal a fundamental misunderstanding: obesity is a chronic disease recognized by the WHO, requiring medical treatment just like diabetes or hypertension. The SURMOUNT-1 study published in the New England Journal of Medicine demonstrated the efficacy and safety of tirzepatide, validating its therapeutic use.
Preparing your responses: the DEAR method
The DEAR technique, used in dialectical behavior therapy, offers a structured framework for responding to remarks: Describe the situation objectively, Express your feelings, Assert your needs, Reinforce positively. For example: “I understand your concern (D). It hurts me when you say it’s cheating (E). I need you to respect my medical decision (A). I would be happy to discuss it calmly (R).”
This method allows for maintaining dialogue while setting clear boundaries. Psychologists specializing in obesity recommend preparing 3 to 4 standard responses adapted to the most frequent situations. It is also useful to distinguish between genuinely curious people and those who project their own anxieties.
Educating without justifying
You have no obligation to justify your medical treatment. However, if you choose to explain, a few key facts can help: obesity involves hormonal mechanisms (GLP-1, GIP, leptin, ghrelin) that go beyond simple willpower. Tirzepatide acts on GLP-1 and GIP receptors, restoring faulty satiety signals. The SURMOUNT clinical trials (phases I to IV) included over 10,000 participants with rigorous follow-up.
- The WHO has recognized obesity as a chronic disease since 1997
- The French National Authority for Health (HAS) recommends medical management beyond a BMI of 30
- GLP-1 agonists have proven their efficacy in over 50 clinical trials
- The relapse rate after diet alone exceeds 95% at 5 years (Mann et al., American Psychologist study)
Managing persistent loved ones
Some loved ones persist despite your explanations. In this case, non-violent communication specialists recommend the broken record technique: calmly repeat the same position without entering into debate. “I understand your point of view, but this is a decision I made with my doctor.” This phrase, repeated as often as necessary, sets a clear boundary without aggression.
If a loved one becomes toxic or actively sabotages your treatment (constant comments, deliberate food temptations), it may be necessary to temporarily limit contact. A study by INSERM (2022) shows that positive social support increases the chances of maintaining weight loss by 40%. Conversely, a hostile environment significantly compromises results.
The role of social networks and communities
Online support groups (forums, Facebook groups, Reddit communities) offer a space for exchange with people sharing the same experience. The MounjaGO app also offers personalized tracking that can serve as concrete support to illustrate your progress to those around you. Sharing objective data (weight curves, improvement in blood markers) can help rationalize the discussion.
However, be cautious with social media: spectacular testimonials can create unrealistic expectations and fuel comparisons. Prioritize reliable medical sources and communities moderated by healthcare professionals. The French Society of Endocrinology (SFE) and the European Association for the Study of Obesity (EASO) offer quality public resources.
When to consult a mental health professional
If social pressure significantly affects your emotional well-being, sleep, or motivation to continue treatment, consulting a psychologist or psychiatrist specializing in obesity is recommended. Cognitive-behavioral therapy (CBT) has demonstrated its effectiveness in developing coping strategies for stigmatization. Some specialized obesity centers (CSO) offer psychological consultations integrated into the care pathway.
Track your progress with the MounjaGO app.
FAQ
How to respond to someone who says taking Mounjaro is cheating?
Obesity is a chronic disease recognized by the WHO. Tirzepatide is a medical treatment validated by rigorous clinical trials (SURMOUNT-1, NEJM 2022). Respond calmly that you are following a treatment prescribed by your doctor, just as one would for diabetes or hypertension.
Should you talk about your GLP-1 treatment with your inner circle?
It’s a personal choice. You have no obligation to disclose your treatment. If you choose to talk about it, prepare a few key responses and select trusted individuals. A specialized psychologist can help you manage this communication.
What to do if a loved one sabotages my Mounjaro treatment?
Set clear boundaries using the broken record technique. If sabotage persists (deliberate temptations, constant comments), temporarily limit contact. Positive social support increases the chances of success by 40% according to INSERM.
Can social pressure affect the efficacy of GLP-1 treatment?
Yes. Chronic stress linked to stigmatization increases cortisol, a hormone that promotes abdominal fat storage. Furthermore, social pressure can compromise therapeutic adherence and emotional well-being, reducing the overall effectiveness of the treatment.